Endoscopic Sleeve Gastroplasty (ESG) is an incision-free endoscopic procedure that uses internal sutures to reduce stomach volume and support weight loss and metabolic improvement. This guide explains how ESG works, who commonly benefits, what outcomes to expect, and how the procedure fits into care pathways for patients in Chicago and LaGrange. For many people living with obesity, ESG offers an effective, lower-risk alternative that avoids abdominal incisions and lengthy hospital stays. You’ll find clear explanations of the No‑Incision ESG technique, evidence-based results, candidacy criteria, step-by-step procedure and recovery expectations, cost and insurance considerations, local provider information, patient experiences from the area, and comparisons with surgical bariatric options. Along the way we include practical checklists, summary tables, and straightforward next steps so you can decide whether ESG is the right option for your weight‑loss journey.
What Is Endoscopic Sleeve Gastroplasty and How Does It Work?
Endoscopic Sleeve Gastroplasty (ESG) is a minimally invasive weight‑loss procedure in which a flexible endoscope is passed through the mouth and uses specialized suturing tools to reduce the stomach’s functional volume and reshape its geometry. By combining reduced stomach capacity with changes in gastric emptying and earlier feelings of fullness, ESG helps patients eat less and lose weight. The procedure is performed without external incisions, usually as an outpatient under sedation or general anesthesia, and falls under the broader field of bariatric endoscopy. Understanding this approach helps explain why ESG can be a suitable alternative to surgical sleeve gastrectomy for carefully selected patients and sets the stage for practical details about the No‑Incision ESG method below.
How Does the No-Incision ESG Procedure Reduce Stomach Size?
The No‑Incision ESG technique uses an endoscopic suturing system advanced through the esophagus to place full‑thickness or near full‑thickness sutures along the stomach’s greater curvature and body. Those sutures fold and plicate the stomach into a narrower tubular shape, which decreases capacity and slows gastric emptying. The endoscope provides direct visualization so sutures can be placed precisely and the new shape confirmed immediately; many centers complete the procedure in under two hours. Because ESG reshapes rather than removes tissue and preserves native anatomy, recovery is often faster than open or laparoscopic surgical options.
Why Is ESG Considered a Minimally Invasive, Non-Surgical Weight Loss Option?
ESG is considered minimally invasive because it uses a natural‑orifice entry (through the mouth) and avoids abdominal incisions, tissue resection, and implanted devices. That reduces incision‑related complications and shortens recovery. Compared with laparoscopic sleeve gastrectomy, ESG typically carries lower immediate procedural risk, shorter observation time, and a quicker return to normal activities—though long‑term weight trajectories vary and depend on patient selection and follow‑up care. Because the stomach is sutured rather than removed, ESG can also be revised endoscopically or later considered alongside surgical options, which makes candidacy and long‑term planning important. These practical differences influence whether patients choose ESG or a surgical approach.
What Are the Benefits and Expected Outcomes of ESG for Weight Loss?
ESG offers measurable weight loss, improvements in obesity‑related conditions, and a relatively rapid recovery compared with traditional surgery. Recent clinical series and meta‑analyses report average total body weight loss (TBWL) around 15–20% at one year, with individual results affected by baseline BMI, adherence to lifestyle changes, and use of adjunctive therapies such as anti‑obesity medications. Beyond weight loss, ESG frequently improves metabolic markers—blood glucose control, blood pressure, and sleep‑related breathing—and can boost physical function and quality of life. The table below summarizes common outcome metrics and realistic timelines.
Endoscopic Sleeve Gastroplasty: Efficacy, Safety, and Mechanisms for Weight Loss
AbstractEndoscopic sleeve gastroplasty (ESG) is a therapeutic endoscopic technique for reducing the size of the gastric reservoir in obese patients, using a full-thickness endoscopic suturing device. The effectiveness of ESG in weight loss is significantly greater than that of high-intensity diet and lifestyle therapy and lower than that of laparoscopic sleeve gastrectomy (LSG). The efficacy at 12 months after ESG in terms of percentage of total body weight loss and excess body weight loss was approximately 16% and 60%, respectively. The well-known predictive factors for increased weight loss by ESG are good compliance with regular monitoring and post-procedure care involving a multidisciplinary team approach. Although the underlying mechanism of weight loss induced by ESG is debatable, delayed gastric emptying and early satiation are some of the proposed mechanisms. The pooled rate of adverse events after ESG reported in several meta-analysis studies ranged from 1.5% to 2.3% and the i Outcome Metric | Clinical Attribute | Typical Value / Timeline |
| Total Body Weight Loss (TBWL) | Average at 12 months | ~15–20% TBWL |
| Comorbidity Improvement | Type 2 diabetes and hypertension | Partial remission or improved control within 6–12 months |
| Recovery Profile | Outpatient return-to-activity | Discharge same day or next-day observation; return to light activity within days |
| Quality of Life | Mobility and psychosocial measures | Notable improvement by 3–6 months |
These findings show that ESG can deliver meaningful weight loss with a faster recovery, while individual outcomes depend on follow‑up and adjunctive care. Knowing expected weight change and health gains helps guide candidacy and procedural planning.
Patients commonly value several practical benefits of ESG; we summarize them next to help your decision making.
Primary benefits patients report include:
- Incisionless Approach: No abdominal cuts, which lowers wound complications and visible scarring.
- Faster Recovery: Most people resume light activity within days and return to many types of work within about a week.
- Significant Weight Loss: Average TBWL at one year typically falls in the mid‑teens percentage range.
- Metabolic Improvements: Many patients see better diabetes control, lower blood pressure, and improved sleep breathing.
These advantages explain why many Chicago and LaGrange residents choose ESG as a practical non‑surgical alternative to bariatric surgery. Next, we describe who is most likely to be a candidate.
Am I a Candidate for Endoscopic Sleeve Gastroplasty? Eligibility and Requirements Explained
Candidacy for ESG balances BMI thresholds, obesity‑related comorbidities, prior surgical history, and personal goals. Selection requires a multidisciplinary evaluation to match the procedure to each person’s medical profile. In practice, ESG is often considered for patients with moderate to severe obesity who want effective weight loss without abdominal incisions. Those with complex anatomy or very high BMI may be better served by surgical options. A thorough pre‑procedure assessment includes medical history, GI evaluation, nutritional and behavioral readiness, and a frank discussion of realistic outcomes and adjunctive treatments. That structured evaluation helps patients understand risks, alternatives, and the follow‑up support needed to sustain results.
What BMI and Medical Conditions Qualify Patients for ESG?
Clinicians commonly consider ESG for patients with BMI roughly between 30–40 kg/m², especially when obesity‑related conditions like type 2 diabetes, hypertension, or sleep apnea are present and a less invasive path is preferred. Patients with lower BMI but significant metabolic disease may be evaluated case‑by‑case as part of individualized obesity medicine. Those with BMI above the typical range are assessed to determine whether surgical options would provide greater long‑term TBWL. Candidate evaluation always includes a detailed medical review and discussion of expectations, since outcomes depend on adherence, follow‑up care, and sometimes combined medical therapy.
What Are the Contraindications and When Is ESG Not Recommended?
Absolute contraindications commonly include untreated or large hiatal hernias, certain severe gastroesophageal conditions, active GI ulcers, or anatomy that prevents safe endoscopic suturing. Relative contraindications include prior complex gastric surgery, uncontrolled psychiatric illness, or substance use that would impair adherence. When contraindications exist, surgical or alternative medical strategies should be considered with a multidisciplinary team. For borderline cases, further testing—such as imaging or diagnostic endoscopy—helps determine feasibility or whether surgical referral is more appropriate. Clear discussion of contraindications ensures patients choose the safest, most effective path.
Endoscopic Sleeve Gastroplasty vs. Laparoscopic Sleeve Gastrectomy: A Meta-Analysis of Outcomes
Background and study aimsEndoscopic sleeve gastroplasty (ESG) is a novel moderately invasive technique in endo-bariatrics as compared to laparoscopic sleeve gastrectomy (LSG). Data is limited as to its efficacy and safety. MethodsWe searched multiple databases from inception through August 2019 to identify studies that reported on ESG in the treatment of obesity. Our goals were to calculate the pooled rates of total weight loss (%TWL), excess weight loss (%EWL), and body mass index (BMI) at 1 month, 6 months, and 12 months with ESG. We included studies that reported on LSG, in a similar time frame as ESG, and compared the 12-month outcomes. ResultsFrom eight studies on ESG (1815 patients), the pooled rates of %TWL at 1 month, 6 months, and 12 months were 8.7 (7.2–10.2), 15.3 (14.1–16.6) and 17.1 (15.1–19.1), respectively. The pooled rates of %EWL at 1 month, 6 months, and 12 months were 31.7 (29.3–34.1), 59.4 (57–61.8) and 63 (51.3–74.6), respectively. The pooled rates of BMI at 1 m, 6 m, and 12 m were 32.6 (31–34.3), 30.4 (29–31.8) and 30 (27.7–32.3, I2= 97), respectively. At 12 months, the pooled %TWL, %EWL and BMI with LSG (7 studies, 2179 patients) were 30.5 (27.4–33.5), 69.3 (60.1–78.4) and 29.3 (27.1–31.4) respectively. On comparison analysis, %TWL with LSG was superior to ESG (P= 0.001). %EWL and BMI were comparable. All adverse events, bleeding and gastro-esophageal reflux disease were significantly lower with ESG when compared to LSG. ConclusionESG demonstrates acceptable weight loss parameters and seems to have a better safety profile when compared to LSG. Patient Profile | Assessment Attribute | Typical Recommendation |
| BMI 30–40 with comorbidities | Eligible with counseling | ESG considered as primary option |
| Prior complex gastric surgery | Structural considerations | May require alternative approach or surgical consult |
| Large hiatal hernia | Anatomical contraindication | Surgical repair or other options recommended |
| Active severe GERD | Relative contraindication | Careful evaluation; surgery may be preferred |
This table summarizes typical eligibility so you can quickly see where you may fall and what next steps look like. Next we cover what the ESG experience and recovery usually involve.
What Should Patients Expect During the ESG Procedure and Recovery?
The ESG care pathway includes pre‑procedure evaluation, procedure‑day logistics under sedation or anesthesia, immediate post‑procedure monitoring, and a staged diet and activity plan with regular follow‑up. Preparation typically involves medical optimization, brief preop testing, and clear fasting or pre‑procedure diet instructions to improve safety and visualization; those instructions also help reduce anxiety and support smoother recovery. On procedure day, the endoscopic treatment is performed in a monitored setting with attentive airway and sedation management, and most patients go home the same day or after a short observation period. Post‑procedure care focuses on staged diet progression, pain control, hydration, and scheduled visits with nutrition and behavioral specialists to maximize durable results.
How Should Patients Prepare for ESG and What Happens on Procedure Day?
Preparing for ESG usually means obtaining medical clearance, pausing certain medications per your provider’s instructions, and following fasting or preop diet guidance to minimize gastric contents. On the day of the procedure you’ll check in, review anesthesia plans, and have the team answer any last‑minute questions. The procedure itself commonly lasts under two hours depending on complexity. Afterward you’ll be monitored in recovery until discharge criteria are met—stable vitals, manageable pain, and tolerance of clear liquids—then discharged home with clear post‑op instructions. These steps reduce risk and set the stage for the first days of recovery.
What Is the Typical Recovery Timeline and Post-Procedure Care Plan?
Recovery after ESG follows a staged progression from clear liquids to purees and then gradual reintroduction of solids over several weeks, with close dietary guidance to ensure nutrition and appropriate portion control. Many patients return to light daily activities within a few days and to non‑strenuous work within about a week; more physically demanding tasks may require two to four weeks. Pain is usually mild and controlled with short courses of analgesics. Scheduled follow‑up with the endoscopist, nutritionist, and behavioral support team is frequent during the first six months, then moves to longer intervals to monitor weight, labs, and comorbidity response. Knowing this timeline helps you plan time off work, arrange support, and prepare for the lifestyle changes that influence long‑term success.
Next, we’ll discuss costs, insurance realities, and financing options—important considerations for many patients.
How Much Does Endoscopic Sleeve Gastroplasty Cost and Is It Covered by Insurance?
ESG costs vary by region, facility, and included services, but reported ranges commonly fall between about $9,000 and $15,000 for the complete procedure when paid out‑of‑pocket. Insurance coverage for ESG can be limited because some payers view endoscopic bariatric procedures as investigational or outside standard surgical benefits; however, detailed documentation of medical necessity and appeals may sometimes secure coverage on a case‑by‑case basis. Many practices offer financing or bundled self‑pay packages to improve access. We recommend requesting an itemized estimate that includes facility fees, anesthesia, pre‑ and post‑operative visits, and follow‑up care. For local pricing and financing specifics, patients may contact TeleSlim Clinic or schedule a consultation with Dr. Jihad Kudsi to receive a personalized estimate and options.
What Are the Average ESG Costs in Chicago and LaGrange?
Local pricing depends on facility choice, anesthesia, follow‑up packages, and whether services like nutrition or behavioral therapy are bundled; typical metropolitan ranges align with the national band of roughly $9,000–$15,000. Cost drivers include whether the procedure is done in an ambulatory endoscopy center versus a hospital outpatient unit, any additional diagnostics, and which perioperative services are included. Requesting an itemized estimate clarifies what you’re paying for and helps you compare offers. Many clinics provide financial coordinators to explain payment plans and expected out‑of‑pocket responsibility. Transparent cost discussions support informed decision making and reduce surprise bills.
Are Insurance and Financing Options Available for ESG?
Insurance coverage for ESG varies widely; many insurers do not routinely cover endoscopic bariatric procedures but may consider appeals with documentation showing prior conservative therapy and relevant comorbidities. Financing options include medical loans, third‑party healthcare financing, and clinic payment plans that spread cost over months. Gather medical records, weight‑loss history, and comorbidity documentation when pursuing coverage to strengthen your case; clinics like TeleSlim Clinic can assist with local financing navigation. Clear discussions about likely coverage outcomes and financing options help set expectations before scheduling.
Here’s a short checklist of common cost components to review during financial planning.
- Procedure Fee: The clinician and technical charge for performing ESG.
- Facility and Anesthesia Fees: Charges for the location and sedation services used during the procedure.
- Pre/Post-Op Care: Consultations, imaging, labs, nutrition and behavioral support that may be billed separately.
Review these items with a clinic coordinator to ensure clarity and to compare offers and financing options effectively.
Why Choose Dr. Jihad Kudsi for Your ESG Procedure in Chicago and LaGrange?
Dr. Jihad Kudsi is dual board‑certified in General Surgery and Obesity Medicine, fellowship‑trained in bariatric surgery, and leads a local, multidisciplinary program for endoscopic and surgical weight‑loss care. His roles with Duly Health and Care and UChicago AdventHealth LaGrange Hospital, and his work founding TeleSlim Clinic, reflect a practice model that combines procedural skill with obesity medicine and coordinated follow‑up. Patients choosing Dr. Kudsi’s team can expect care that integrates endoscopic technique, medical weight‑management principles, and coordinated support from nutrition and behavioral specialists to optimize outcomes. For Chicago and LaGrange residents exploring No‑Incision ESG, Dr. Kudsi’s practice emphasizes personalized evaluation and open discussion about candidacy and expected results.
What Are Dr. Kudsi’s Qualifications and Experience in Bariatric and Obesity Medicine?
Dr. Kudsi holds dual board certification in General Surgery and Obesity Medicine and completed fellowship training in bariatric surgery, combining operative expertise with medical management of obesity. His leadership roles in regional health systems enable coordinated access to perioperative services and multidisciplinary follow‑up, supporting safe performance of No‑Incision ESG within a structured clinical pathway. Patients benefit from a provider who understands both procedural techniques and the medical therapies that support durable weight loss.
How Does Dr. Kudsi’s Personalized Approach Enhance Patient Outcomes?
Dr. Kudsi’s approach centers on individualized treatment plans that pair ESG with nutrition counseling, behavior change support, and—when appropriate—adjunctive weight‑loss medications to improve results. Multidisciplinary coordination provides structured follow‑up, lab monitoring, and medication adjustments as weight and metabolic markers change, which helps adherence and durability. The practice emphasizes shared decision‑making to align chosen interventions with patient goals and safety, and offers clear counseling on recovery and next steps if further intervention is needed. If you’re interested in a tailored evaluation, request a consultation to discuss whether this integrated approach fits your goals.
What Do Local Patients Say About Their ESG Success Stories?
Patients in the Chicago and LaGrange area report meaningful lifestyle changes after ESG, including weight loss, improved mobility, and better control of obesity‑related conditions that make daily activities easier. Practice summaries show many patients achieving mid‑teens percent TBWL at one year with parallel improvements in diabetes control and blood pressure—outcomes that reflect the combined effect of reduced stomach volume plus structured follow‑up. Patients also value the convenience of outpatient treatment and faster recovery compared with surgery, particularly when balancing work and family. If you’d like to review practice‑approved testimonials or case summaries, TeleSlim Clinic can explain how to request or view them during a consultation.
How Have Chicago and LaGrange Residents Benefited from ESG?
Local patients who choose ESG commonly highlight a faster return to routine life, meaningful percent TBWL, and measurable improvement in comorbidities such as diabetes and sleep disturbances—changes that translate into better day‑to‑day energy and activity tolerance. Access to coordinated care—endoscopic expertise combined with nutrition and behavioral support—helps convert procedural gains into long‑term health benefits rather than short‑term weight change. Regional patients also appreciate outpatient scheduling and less time away from work compared with surgical options, making ESG a practical tool in local obesity‑management pathways.
What Support and Follow-Up Care Do ESG Patients Receive Locally?
After ESG, local follow‑up typically includes early post‑procedure checks, staged nutritional counseling, behavioral therapy sessions, and periodic metabolic monitoring to track weight and comorbidity response. Clinics in the region schedule frequent visits during the first three to six months, then space them out as patients stabilize and progress, with the ability to escalate care if additional interventions or medication adjustments are helpful. Collaboration with local hospitals and outpatient services ensures access to diagnostic testing and surgical consultation if needed. This structured support is a key factor in long‑term success and is emphasized during initial consultations.
How Does ESG Compare to Other Bariatric Procedures?
ESG sits between conservative medical management and more invasive surgical procedures on the bariatric spectrum, offering meaningful weight loss with less invasiveness and a faster recovery. Compared with laparoscopic sleeve gastrectomy and gastric bypass, ESG is incisionless and conceptually reversible, but typically produces lower TBWL and may require adjunctive therapies for some patients to approach surgical results. Risk profiles differ: ESG generally has lower immediate perioperative morbidity but may have different long‑term durability and revision rates. Choosing the right option depends on patient goals, baseline BMI, comorbidity severity, and openness to staged approaches. Shared decision‑making with your bariatric surgeon and obesity medicine specialist helps determine the best path.
What Are the Key Differences Between ESG and Surgical Sleeve Gastrectomy?
ESG reduces stomach capacity with endoscopic sutures without removing tissue, while surgical sleeve gastrectomy removes the stomach’s greater curvature, producing a permanent anatomical change that often yields greater TBWL. ESG typically offers faster recovery and fewer incision‑related risks, but surgical sleeve generally achieves higher and more durable TBWL in appropriately selected patients. Reversibility and risk trade‑offs matter: ESG is less invasive and may be revisable endoscopically, while surgical sleeve is permanent but may be preferred for patients with very high BMI or severe metabolic disease. Your goals and medical assessment guide which option is best.
Procedure | Invasiveness | Typical TBWL (12 mo) | Recovery | Reversibility |
| ESG | Endoscopic, incisionless | Moderate (~15–20%) | Shorter, outpatient | Potentially revisable endoscopically |
| Surgical Sleeve Gastrectomy | Laparoscopic resection | Higher (often >20%) | Longer recovery, hospital stay possible | Permanent resection |
| Gastric Bypass | Laparoscopic with rerouting | Highest for metabolic effect | Longer recovery, more complex | Permanent, metabolic effects strong |
When Is ESG a Better Option Than Gastric Bypass or Other Weight Loss Surgeries?
ESG may be preferable for patients who want significant weight loss but prioritize a shorter recovery, avoidance of abdominal incisions, or who are not ideal surgical candidates because of comorbidities or personal preferences. It can also serve as a first‑line procedural step for patients with moderate obesity who want to try a less invasive intervention before committing to irreversible surgery. Conversely, gastric bypass or surgical sleeve are preferred for patients with very high BMI, severe metabolic disease needing robust metabolic effect, or anatomical factors that make endoscopic suturing infeasible. Shared decision‑making with both a bariatric surgeon and an obesity medicine specialist helps determine when ESG is the right fit.
What Are the Most Common Questions About Endoscopic Sleeve Gastroplasty?
This FAQ section answers common patient questions with concise, practical information tailored for Chicago and LaGrange audiences. The responses are intended to help you make quick, informed decisions and prepare for next steps.
What Is ESG and How Does It Help With Weight Loss?
ESG is an endoscopic procedure that reduces stomach volume with internal sutures placed through the mouth. By promoting earlier satiety and slowing gastric emptying, ESG helps reduce caloric intake and support weight loss. The procedure produces a physical change in stomach shape that, when combined with nutrition and behavioral support, helps many patients achieve clinically meaningful TBWL. Understanding this mechanism clarifies why ESG is an option for people seeking non‑surgical weight‑loss procedures.
How Long Is Recovery After ESG and When Can I Return to Work?
Most patients resume light daily activities within several days and typical office work within about one week, while more strenuous activity may require two to four weeks depending on individual recovery. Immediate post‑procedure discomfort is usually manageable with short courses of analgesics and rarely requires prolonged opioid use. Dietary progression and hydration are central to early recovery. Return‑to‑work timing depends on job demands and personal healing, and your provider will give personalized guidance during follow‑up to help plan a smooth return.
Is ESG Covered by Insurance and What Are the Financing Options?
Insurance coverage for ESG is variable and often limited; many payers view endoscopic bariatric procedures as nonstandard, though appeals with strong clinical documentation and proof of prior conservative therapy can be successful in some cases. Financing options include medical loans, third‑party healthcare financing, and clinic payment plans. We recommend requesting an itemized cost estimate and discussing payment options during consultation. TeleSlim Clinic can help local patients understand likely coverage outcomes and available financing pathways so they can plan with confidence.
Who Is the Best Candidate for ESG in the Chicago Area?
The best ESG candidates are people with moderate to severe obesity who want meaningful weight loss from a less invasive outpatient procedure and who are willing to engage in structured follow‑up and lifestyle change. Typical candidates include those within the BMI ranges and with comorbidities amenable to endoscopic intervention, but individualized evaluation is required to assess anatomical suitability and readiness for behavior change. A multidisciplinary consultation in Chicago or LaGrange will determine candidacy and create a personalized care plan. Scheduling an evaluation with a qualified provider is the first step toward deciding whether ESG aligns with your health goals.
- Next step: Book a consultation to confirm candidacy and receive a personalized estimate.
- Documentation: Gather prior weight‑loss attempts and medical records to inform the evaluation.
- Support: Be prepared to engage with nutrition and behavioral follow‑up to maximize outcomes.
These practical action items translate information into concrete steps that prepare you for informed decision making about ESG.
Candidate Profile | Key Attribute | Recommendation |
| Moderate obesity with comorbidities | BMI ~30–40 | ESG often considered |
| Very high BMI or complex anatomy | BMI >40 or prior GI surgery | Surgical options may be advised |
| Uncontrolled GI conditions | Active ulcers or large hiatal hernia | Contraindicated until addressed |
This final table clarifies typical candidate pathways and supports informed discussions about next steps and local resources.
Frequently Asked Questions
What lifestyle changes should I expect after undergoing ESG?
After ESG, you’ll be asked to adopt lasting lifestyle changes to maximize weight loss and health benefits. Expect a staged diet that moves from clear liquids to solids over several weeks, a regular physical activity plan, and ongoing nutritional and behavioral support. These elements reinforce the procedure’s effects and are key to long‑term success. Working with a multidisciplinary team gives you the structure and accountability most patients find helpful.
How does ESG compare to other non-surgical weight loss options?
ESG is generally more effective than diet alone and often produces more sustained results than medication by creating a physiological change in stomach shape that promotes early fullness. Unlike medications, which may vary in effectiveness and side effects, ESG provides a structural intervention that supports reduced intake. That said, ESG works best when paired with lifestyle modification and, where appropriate, adjunctive pharmacotherapy—each option plays a role in a comprehensive obesity strategy.
What are the potential risks and complications associated with ESG?
ESG is considered safe, but like any procedure it carries risks. Possible complications include bleeding, infection, and anesthesia‑related events, and some patients experience nausea, vomiting, or abdominal discomfort after the procedure. Serious complication rates reported in meta‑analyses range roughly from 1.5% to 2.3%. We encourage a detailed discussion of risks with your provider so you can make an informed decision.
How long do the results of ESG last?
ESG results can be durable, but long‑term success depends heavily on adherence to lifestyle changes and follow‑up care. Studies show average TBWL of 15–20% at one year, and maintaining those gains typically requires continued healthy eating, physical activity, and regular monitoring. Ongoing follow‑up with your care team helps track progress and make adjustments as needed to sustain results over time.
Can ESG be repeated if necessary?
Yes—ESG can be revisited in some cases, particularly if the initial weight loss is insufficient or weight regain occurs. The endoscopic approach allows for revision in many circumstances, but repeat procedures should be considered alongside comprehensive lifestyle and medical strategies. A thorough reassessment by your provider will determine whether a repeat ESG or another intervention is the best option.
What support systems are available for ESG patients post-procedure?
After ESG, patients commonly receive a combination of scheduled follow‑up visits, nutrition counseling, and behavioral therapy. Many clinics also offer support groups or peer resources where patients can share strategies and encouragement. These supports help patients navigate dietary changes, maintain motivation, and achieve long‑term success in weight management.
Conclusion
Endoscopic Sleeve Gastroplasty (ESG) is a minimally invasive option that can produce significant weight loss and meaningful metabolic improvements with a faster recovery than many traditional surgical procedures. By understanding the benefits, candidacy criteria, and practical next steps, you can decide whether ESG fits your health goals. To explore this option, schedule a consultation and talk with our team about personalized care and what to expect.
